{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:39:41Z","timestamp":1790962781384,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bcp.2011.07.103","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T23:17:45Z","timestamp":1312759065000},"page":"1740-1746","source":"Crossref","is-referenced-by-count":25,"title":["Valproic acid utilizes the isoleucine breakdown pathway for its complete \u03b2-oxidation"],"prefix":"10.1016","volume":"82","author":[{"given":"Paula B.M.","family":"Lu\u00eds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos P.","family":"Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Ofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk","family":"IJlst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moedas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edsa","family":"Diogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Tavares","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida F.B.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.07.103_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2710.2005.00671.x","article-title":"Valproate: a simple chemical with so much to offer","volume":"30","author":"Peterson","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.bcp.2011.07.103_bib0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2011.07.103_bib0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nurt.2006.11.007","article-title":"Valproic acid: second generation","volume":"4","author":"Bialer","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bcp.2011.07.103_bib0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2011.07.103_bib0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(05)67098-5","article-title":"Depletion of latent HIV-1 infection in vivo: a proof-of-concept study","volume":"366","author":"Lehrman","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2011.07.103_bib0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/15563659509018000","article-title":"Life threatening intoxication with sodium valproate","volume":"33","author":"Andersen","year":"1995","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.bcp.2011.07.103_bib0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2011.07.103_bib0040","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/0140-6736(93)90748-6","article-title":"Unusual electron microscopic changes in valproate-associated liver failure","volume":"341","author":"Caparros-Lefebvre","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2011.07.103_bib0045","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbabio.2007.06.007","article-title":"Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation","volume":"1767","author":"Luis","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2011.07.103_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/A:1005398516208","article-title":"Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro","volume":"20","author":"Silva","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bcp.2011.07.103_bib0055","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/0006-2952(83)90054-0","article-title":"The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats","volume":"32","author":"Turnbull","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.07.103_bib0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj2160233","article-title":"Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA","volume":"216","author":"Coude","year":"1983","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2011.07.103_bib0065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jhep.2010.11.031","article-title":"New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA","volume":"55","author":"Aires","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2011.07.103_bib0070","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1212\/WNL.44.4.742","article-title":"Interaction between valproate and branched-chain amino acid metabolism","volume":"44","author":"Anderson","year":"1994","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.bcp.2011.07.103_bib0075","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1124\/dmd.110.037606","article-title":"Role of isovaleryl-CoA dehydrogenase and short branched-chain acyl-CoA dehydrogenase in the metabolism of valproic acid: implications for the branched-chain amino acid oxidation pathway","volume":"39","author":"Luis","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2011.07.103_bib0080","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bcp.2009.10.011","article-title":"Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis","volume":"79","author":"Aires","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.07.103_bib0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bcp.2011.07.103_bib0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0090-9556(25)08901-9","article-title":"Studies on the beta-oxidation of valproic acid in rat liver mitochondrial preparations","volume":"19","author":"Bjorge","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2011.07.103_bib0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/bi00216a012","article-title":"Mitochondrial metabolism of valproic acid","volume":"30","author":"Li","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2011.07.103_bib0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/abio.2000.4947","article-title":"Synthesis and intramitochondrial levels of valproyl-coenzyme A metabolites","volume":"290","author":"Silva","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2011.07.103_bib0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj3620755","article-title":"Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase","volume":"362","author":"Silva","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2011.07.103_bib0110","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/dmd...","article-title":"Valproyl-dephosphoCoA: a novel metabolite of valproate formed in vitro in rat liver mitochondria","volume":"32","author":"Silva","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2011.07.103_bib0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbalip.2007.01.010","article-title":"Studies on the extra-mitochondrial CoA-ester formation of valproic and Delta4-valproic acids","volume":"1771","author":"Aires","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2011.07.103_bib0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-4165(90)90079-C","article-title":"The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase","volume":"1034","author":"Ito","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2011.07.103_bib0125","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/375116","article-title":"2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene","volume":"72","author":"Ofman","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bcp.2011.07.103_bib0130","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1203\/00006450-200006000-00025","article-title":"2-Methylbutyryl-coenzyme A dehydrogenase deficiency: a new inborn error of l-isoleucine metabolism","volume":"47","author":"Gibson","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bcp.2011.07.103_bib0135","first-page":"2064","article-title":"Characterization of the human omega-oxidation pathway for omega-hydroxy-very-long-chain fatty acids","volume":"22","author":"Sanders","year":"2008","journal-title":"Fed Am Soc Exp Biol J"},{"key":"10.1016\/j.bcp.2011.07.103_bib0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2011.07.103_bib0145","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0021-9258(17)32751-5","article-title":"Purification and properties of pig heart crotonase and the presence of short chain and long chain enoyl coenzyme A hydratases in pig and guinea pig tissues","volume":"252","author":"Fong","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.07.103_bib0150","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.49.5.1444","article-title":"Biotin catabolism is accelerated in adults receiving long-term therapy with anticonvulsants","volume":"49","author":"Mock","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2011.07.103_bib0155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","article-title":"A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation","volume":"33","author":"Houten","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bcp.2011.07.103_bib0160","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/geno.1996.4597","article-title":"Human mitochondrial enoyl-CoA hydratase gene (ECHS1): structural organization and assignment to chromosome 10q26.2-q26.3","volume":"40","author":"Janssen","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.bcp.2011.07.103_bib0165","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/j.1742-4658.2006.05218.x","article-title":"Biochemical characterization of human 3-methylglutaconyl-CoA hydratase and its role in leucine metabolism","volume":"273","author":"Mack","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2011.07.103_bib0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymgme.2006.07.010","article-title":"Inborn errors of isoleucine degradation: a review","volume":"89","author":"Korman","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bcp.2011.07.103_bib0175","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10545-005-0501-3","article-title":"Inhibition of energy metabolism by 2-methylacetoacetate and 2-methyl-3-hydroxybutyrate in cerebral cortex of developing rats","volume":"28","author":"Rosa","year":"2005","journal-title":"J Inherit Metab Dis"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211006484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211006484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T09:18:19Z","timestamp":1741425499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211006484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0006295211006484"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.07.103","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}